Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.15)
# 3,077
Out of 4,667 analysts
231
Total ratings
27.18%
Success rate
-12.98%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Reiterates: Buy | $68 | $45.76 | +48.60% | 27 | Nov 20, 2024 | |
| KYTX Kyverna Therapeutics | Maintains: Neutral | $7 → $6 | $4.12 | +45.63% | 5 | Nov 20, 2024 | |
| NGNE Neurogene | Reiterates: Buy | $55 | $15.33 | +258.77% | 12 | Nov 19, 2024 | |
| RANI Rani Therapeutics Holdings | Reiterates: Buy | $9 | $2.05 | +339.02% | 14 | Nov 19, 2024 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $18.62 | +136.31% | 11 | Nov 18, 2024 | |
| ZURA Zura Bio | Reiterates: Neutral | $5 | $2.90 | +72.41% | 4 | Nov 18, 2024 | |
| TIL Instil Bio | Reiterates: Buy | $110 | $23.36 | +370.89% | 13 | Nov 18, 2024 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $21 → $23 | $6.12 | +275.82% | 5 | Nov 14, 2024 | |
| ALMS Alumis | Maintains: Buy | $30 → $26 | $9.64 | +169.71% | 2 | Nov 14, 2024 | |
| KRRO Korro Bio | Reiterates: Buy | $115 | $47.00 | +144.68% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $73 | $40.14 | +81.86% | 31 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1 | $1.03 | -2.91% | 10 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $15.87 | +89.04% | 16 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.87 | - | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $41 | $16.94 | +142.03% | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $0.99 | +402.97% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $4.55 | +207.69% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.26 | +296.83% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $22.20 | +102.70% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.65 | +324.24% | 6 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.86 | +827.64% | 10 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $2,440 | $0.34 | +719,876.39% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18,000 → $14,000 | $0.63 | +2,222,122.22% | 2 | Apr 27, 2023 |
Halozyme Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $68
Current: $45.76
Upside: +48.60%
Kyverna Therapeutics
Nov 20, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $4.12
Upside: +45.63%
Neurogene
Nov 19, 2024
Reiterates: Buy
Price Target: $55
Current: $15.33
Upside: +258.77%
Rani Therapeutics Holdings
Nov 19, 2024
Reiterates: Buy
Price Target: $9
Current: $2.05
Upside: +339.02%
Summit Therapeutics
Nov 18, 2024
Reiterates: Buy
Price Target: $44
Current: $18.62
Upside: +136.31%
Zura Bio
Nov 18, 2024
Reiterates: Neutral
Price Target: $5
Current: $2.90
Upside: +72.41%
Instil Bio
Nov 18, 2024
Reiterates: Buy
Price Target: $110
Current: $23.36
Upside: +370.89%
Lexeo Therapeutics
Nov 14, 2024
Maintains: Buy
Price Target: $21 → $23
Current: $6.12
Upside: +275.82%
Alumis
Nov 14, 2024
Maintains: Buy
Price Target: $30 → $26
Current: $9.64
Upside: +169.71%
Korro Bio
Nov 13, 2024
Reiterates: Buy
Price Target: $115
Current: $47.00
Upside: +144.68%
Nov 13, 2024
Reiterates: Buy
Price Target: $73
Current: $40.14
Upside: +81.86%
Nov 12, 2024
Reiterates: Neutral
Price Target: $1
Current: $1.03
Upside: -2.91%
Nov 11, 2024
Maintains: Buy
Price Target: $32 → $30
Current: $15.87
Upside: +89.04%
Nov 11, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.87
Upside: -
Nov 8, 2024
Maintains: Buy
Price Target: $45 → $41
Current: $16.94
Upside: +142.03%
Nov 8, 2024
Maintains: Buy
Price Target: $6 → $5
Current: $0.99
Upside: +402.97%
Nov 6, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $4.55
Upside: +207.69%
Nov 6, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $1.26
Upside: +296.83%
Oct 31, 2024
Reiterates: Buy
Price Target: $45
Current: $22.20
Upside: +102.70%
Oct 15, 2024
Reiterates: Buy
Price Target: $7
Current: $1.65
Upside: +324.24%
Jun 28, 2024
Reiterates: Buy
Price Target: $8
Current: $0.86
Upside: +827.64%
Sep 6, 2023
Maintains: Buy
Price Target: $160 → $2,440
Current: $0.34
Upside: +719,876.39%
Apr 27, 2023
Maintains: Buy
Price Target: $18,000 → $14,000
Current: $0.63
Upside: +2,222,122.22%